| pubmed-article:17206703 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17206703 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17206703 | lifeskim:mentions | umls-concept:C0009324 | lld:lifeskim |
| pubmed-article:17206703 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
| pubmed-article:17206703 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:17206703 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:17206703 | lifeskim:mentions | umls-concept:C0666743 | lld:lifeskim |
| pubmed-article:17206703 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:17206703 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:17206703 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17206703 | pubmed:dateCreated | 2007-5-2 | lld:pubmed |
| pubmed-article:17206703 | pubmed:abstractText | Our objective is to report the outcome of infliximab (IFX) in ulcerative colitis (UC) patients from a single center and to identify predictors of early clinical response. | lld:pubmed |
| pubmed-article:17206703 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17206703 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17206703 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17206703 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17206703 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17206703 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17206703 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17206703 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17206703 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17206703 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:17206703 | pubmed:issn | 1078-0998 | lld:pubmed |
| pubmed-article:17206703 | pubmed:author | pubmed-author:RutgeertsPaul... | lld:pubmed |
| pubmed-article:17206703 | pubmed:author | pubmed-author:VermeireSéver... | lld:pubmed |
| pubmed-article:17206703 | pubmed:author | pubmed-author:KatsanosKonst... | lld:pubmed |
| pubmed-article:17206703 | pubmed:author | pubmed-author:NomanMajaM | lld:pubmed |
| pubmed-article:17206703 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:17206703 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:17206703 | pubmed:author | pubmed-author:HoffmanIlseI | lld:pubmed |
| pubmed-article:17206703 | pubmed:author | pubmed-author:SchnitzlerFab... | lld:pubmed |
| pubmed-article:17206703 | pubmed:author | pubmed-author:FerranteMarcM | lld:pubmed |
| pubmed-article:17206703 | pubmed:author | pubmed-author:ArijsIngridI | lld:pubmed |
| pubmed-article:17206703 | pubmed:author | pubmed-author:GeboesJ... | lld:pubmed |
| pubmed-article:17206703 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17206703 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:17206703 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17206703 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17206703 | pubmed:pagination | 123-8 | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:meshHeading | pubmed-meshheading:17206703... | lld:pubmed |
| pubmed-article:17206703 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17206703 | pubmed:articleTitle | Predictors of early response to infliximab in patients with ulcerative colitis. | lld:pubmed |
| pubmed-article:17206703 | pubmed:affiliation | Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium. marcferrante@yahoo.com | lld:pubmed |
| pubmed-article:17206703 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17206703 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:17206703 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17206703 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17206703 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17206703 | lld:pubmed |
